北米の核医学/放射性医薬品市場予測2024年：種類別、用途別

LINEで送る

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Market Scope
1.2.2 Markets Covered
1.2.3 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
2 Research Methodology (Page No. – 24)
2.1 Research Data
2.2 Research Methodology Steps
2.2.1 Secondary Data
2.2.1.1 Secondary Sources
2.2.2 Primary Data
2.2.3 Primary Sources
2.2.4 Key Insights From Primary Sources
2.2.5 Market Size Estimation Methodology
2.2.6 Revenue Mapping-Based Market Estimation
2.2.7 Market Data Estimation and Triangulation
2.2.8 Assumptions of the Study
3 Executive Summary (Page No. – 34)
4 Premium Insights (Page No. – 37)
4.1 North American Nuclear Medicine Market Overview
4.2 Market, By Type, (2019)
4.3 North American Diagnostic Nuclear Medicine Procedures Market, By Type, 2019–2024
4.4 North American Therapeutic Procedures Market, By Type (2019–2024)
5 Market Overview (Page No. – 40)
5.1 Introduction
5.1.1 Market Dynamics
5.1.2 Drivers
5.1.2.1 Increasing Incidence and Prevalence of Target Conditions
5.1.2.2 Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
5.1.2.3 Initiatives to Lessen the Demand-Supply Gap of Mo-99
5.1.3 Restraints
5.1.3.1 Short Half-Life of Radiopharmaceuticals
5.1.4 Opportunities
5.1.4.1 Use of Radiopharmaceuticals in Neurological Applications
6 North American Nuclear Medicine/ Radiopharmaceuticals Market: Pipeline Assessment (Page No. – 43)
6.1 Introduction
6.2 Diagnostic Radioisotopes
6.3 Therapeutic Radioisotopes
7 North American Nuclear Medicine/ Radiopharmaceuticals Market, By Type (Page No. – 49)
7.1 Introduction
7.2 Diagnostic Nuclear Medicine
7.2.1 SPECT Radiopharmaceuticals
7.2.1.1 TC-99m
7.2.1.2 TL-201
7.2.1.3 GA-67
7.2.1.4 I-123
7.2.1.5 Other SPECT Isotopes
7.2.2 Pet Radiopharmaceuticals
7.2.2.1 F-18
7.2.2.2 RU-82
7.2.2.3 Other Pet Isotopes
7.3 Therapeutic Nuclear Medicine
7.3.1 Alpha Emitters
7.3.1.1 RA-223
7.3.2 Beta Emitters
7.3.2.1 Iodine-131
7.3.2.2 Y-90
7.3.2.3 SM-153
7.3.2.4 LU-177
7.3.2.5 RH-186
7.3.2.6 Other Beta Emitters
7.3.3 Brachytherapy Isotopes
7.3.3.1 Iodine-125
7.3.3.2 Iridium-192
7.3.3.3 Palladium-103
7.3.3.4 Cesium-131
7.3.3.5 Other Brachytherapy Isotopes
8 North American Nuclear Medicine/Radiopharmaceuticals Market, By Application (Page No. – 69)
8.1 Introduction
8.2 Diagnostic Applications
8.2.1 SPECT Applications
8.2.1.1 Cardiology
8.2.1.1.1 Rising Incidence of CVD has Increased Demand for Cardiac Diagnostic Scans
8.2.1.2 Bone Scans
8.2.1.2.1 Precision of SPECT in Bone Scanning has Driven Dependence on the Technology
8.2.1.3 Thyroid Applications
8.2.1.3.1 Introduction of Dual SPECT/CT Imaging is an Important Trend in the Thyroid Applications Segment
8.2.1.4 Pulmonary Scans
8.2.1.4.1 SPECT/CT has Shown High Accuracy and Sensitivity in Pulmonary Embolism Applications
8.2.1.5 Other SPECT Applications
8.2.2 PET Applications
8.2.2.1 Oncology
8.2.2.1.1 Increasing Cancer Incidence Will Fuel Market Growth
8.2.2.2 Cardiology
8.2.2.2.1 Growing Preference for FDG in Cardiac Imaging is Likely to Boost Market Growth
8.2.2.3 Neurology
8.2.2.3.1 R&D Into Alzheimer’s Disease has Positively Affected Demand for Nuclear Medicine
8.2.2.4 Other PET Applications
8.3 Therapeutic Applications
8.3.1 Thyroid Indications
8.3.1.1 Increasing Prevalence of Thyroid Disorders Will Fuel Market Growth
8.3.2 Bone Metastasis
8.3.2.1 Introduction of Novel Therapies for Bone Metastasis Will Positively Impact the Market
8.3.3 Lymphoma
8.3.3.1 Development of New Isotopes for the Treatment of Lymphoma Presents Huge Growth Opportunities
8.3.4 Endocrine Tumors
8.3.4.1 US Dominates the Therapeutic Nuclear Medicine Market for Endocrine Tumor Applications
8.3.5 Other Indications
9 North American Nuclear Medicine/Radiopharmaceuticals Market: Procedural Volume Assessment (Page No. – 81)
9.1 Introduction
9.2 Diagnostic Procedures
9.2.1 SPECT Procedures
9.2.2 PET Procedures
9.3 Therapeutic Procedures
9.3.1 Beta Emitter Procedures
9.3.2 Alpha Emitter Procedures
9.3.3 Brachytherapy Procedures
10 North American Nuclear Medicine/Radiopharmaceuticals Market, By Country (Page No. – 86)
10.1 Introduction
10.1.1 US
10.1.1.1 The US Holds the Largest Share of the North American Market
10.1.2 Canada
10.1.2.1 Investments to Secure Medical Isotope Supply are Likely to Boost Market Growth

11 Competitive Landscape (Page No. – 100)
11.1 Overview
11.2 Competitive Leadership Mapping
11.2.1 Visionary Leaders
11.2.2 Innovators
11.2.3 Dynamic Differentiators
11.2.4 Emerging Companies
11.3 Competitive Scenario
11.3.1 Product Launches & Approvals
11.3.2 Expansions
11.3.3 Acquisitions
11.3.4 Agreements,Partnerships, & Collaborations
12 Company Profile (Page No. – 106)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 Cardinal Health
12.2 GE Healthcare
12.3 Curium
12.4 Lantheus Medical Imaging, Inc.
12.5 Bayer AG
12.6 Bracco Imaging S.P.A.
12.7 Eczacibaþi-Monrol Nuclear Products
12.8 Nordion, Inc. (A Subsidiary of Sterigenics International)
12.9 Advanced Accelerator Applications (AAA) (A Part of Novartis)
12.10 NTP Radioisotopes Soc, LTD. (A Subsidiary of South African Nuclear Energy Corporation)
12.11 Joint Stock Company Isotope (JSC Isotope)
12.12 Northstar Medical Radioisotopes, LLC
12.13 Eckert & Ziegler
12.14 Jubilant Draximage, Inc. (A Subsidiary of Jubilant Pharma)
12.15 Pharmalogic
12.16 Institute of Isotopes Co., LTD.
12.17 Sinotau Pharmaceuticals Group
12.18 Isotopia Molecular Imaging Limited
12.19 Shine Medical Technologies
12.20 Global Medical Solutions, LTD.
12.21 FDA Approved Radiopharmaceuicals
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 150)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

関連データはありません。

※当サイトのレポート紹介カバレッジ
■産業：医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域：世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類：市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様